Disclosed positions

Estimated from their latest filings — positions may have changed since

$165.6K

combined est. value

Stock	Shares	Price	Value	Weight	As of
TLSIWTriSalus Life Sciences, Inc.	147,555	$0.8000	$118.0K	71%	2026-05-15
CHRSCoherus Oncology, Inc.	30,000	$1.59	$47.5K	29%	2026-06-05

TLSIW

TriSalus Life Sciences, Inc.

$118.0K

147,555 sh

CHRS

Coherus Oncology, Inc.

$47.5K

30,000 sh

Activity

Open-market buy & sell volume

BuySell

Total +$151.8K bought · −$73.9K sold

Most bought

TLSIW

$151.8K

All filings on record

Every Form 4 transaction we track for this filer

all 3buys 1sells 1

Stock	Transaction	Date	~6mo later
CHRSCoherus Oncology, Inc.	Grant — · 30,000 sh	2026-06-05	—
TLSIWTriSalus Life Sciences, Inc.	Buy $151.8K · 60,000 sh	2026-05-15	in progress
CHRSCoherus Oncology, Inc.	Sell $73.9K · 99,988 sh	2025-05-23	—

CHRSGrant

2026-06-05 · Coherus Oncology, Inc.

30,000

—

TLSIWBuy

2026-05-15 · TriSalus Life Sciences, Inc.

$151.8K

in progress

CHRSSell

2025-05-23 · Coherus Oncology, Inc.

$73.9K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.